Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Glycosensors And Diagnostics LLC operates in the Biotechnology & Pharmaceuticals technology area, with 1 pending office action currently on file. This 1 pending office action represents the current state of the company's active patent prosecution. The portfolio is located within 1 distinct art unit, suggesting a specialized focus on diagnostic or sensor technologies within the biotech field. This concentration indicates that the company is focusing its intellectual property efforts on a specific technical application rather than a broad range of biological tools.
The company's patent applications are being reviewed by 1 distinct examiner, which simplifies the management of the portfolio but concentrates the risk. STOICA, ELLY GERALD is the busiest examiner, responsible for the 1 pending office action. This means the company's immediate progress toward patent allowance is tied to the specific feedback of this examiner. Practitioners should focus on the examiner's history to anticipate potential hurdles in this single active case.
For practitioners, the fact that there is 1 distinct art unit and 1 distinct examiner indicates a narrow prosecution front. Since the busiest examiner pending count is 1, there are no other active matters to provide alternative routes for securing intellectual property in this technology area. This singular focus suggests a high-stakes approach to a specific diagnostic innovation.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STOICA, ELLY GERALD | 1 | 66.9% | +22.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18241459 | REAGENTS FOR DETECTION OF N-GLYCOSYLATION | STOICA, ELLY GERALD | — |
| Art Unit | Apps |
|---|---|
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18241459 | REAGENTS FOR DETECTION OF N-GLYCOSYLATION | STOICA, ELLY GERALD | 1693 | §112 | Non-Final OA | — | Pending | Sep 01, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial